Einzeltreffer — DigiBib

Understanding how the infectious disease burden was affected throughout the COVID-19 pandemic is pivotal to identifying potential hot spots and guiding future mitigation measures. Therefore, our study aimed to analyze the changes in the rate of new cases of Poland's most frequent infectious diseases during the entire COVID-19 pandemic and after the influx of war refugees from Ukraine. We performed a registry-based population-wide study in Poland to analyze the changes in the rate of 24 infectious disease cases from 2020 to 2023 and compared them to the prepandemic period (2016-2019). Data were collected from publicly archived datasets of the Epimeld database published by national epidemiological authority institutions. The rate of most of the studied diseases (66.6%) revealed significantly negative correlations with the rate of SARS-CoV-2 infections. For the majority of infectious diseases, it substantially decreased in 2020 (in case of 83%) and 2021 (63%), following which it mostly rebounded to the prepandemic levels and, in some cases, exceeded them in 2023 when the exceptionally high annual rates of new cases of scarlet fever, Streptococcus pneumoniae infections, HIV infections, syphilis, gonococcal infections, and tick-borne encephalitis were noted. The rate of Clostridioides difficile enterocolitis was two-fold higher than before the pandemic from 2021 onward. The rate of Legionnaires' disease in 2023 also exceeded the prepandemic threshold, although this was due to a local outbreak unrelated to lifted COVID-19 pandemic restrictions or migration of war refugees. The influx of war migrants from Ukraine could impact the epidemiology of sexually transmitted diseases. The present analysis indicates that continued efforts are needed to prevent COVID-19 from overwhelming healthcare systems again and decreasing the control over the burden of other infectious diseases. It also identifies the potential tipping points that require additional mitigation measures, which are also discussed in the paper, to avoid escalation in the future.

Titel:	The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration.
Autor/in / Beteiligte Person:	Rzymski, P ; Zarębska-Michaluk, D ; Parczewski, M ; Genowska, A ; Poniedziałek, B ; Strukcinskiene, B ; Moniuszko-Malinowska, A ; Flisiak, R
Link:	Zum Volltext
Zeitschrift:	Journal of medical virology, Jg. 96 (2024-05-01), Heft 5, S. e29651
Veröffentlichung:	New York Ny : Wiley-Liss ; <i>Original Publication</i>: New York, Liss., 2024
Medientyp:	academicJournal
ISSN:	1096-9071 (electronic)
DOI:	10.1002/jmv.29651
Schlagwort:	Humans Ukraine epidemiology Poland epidemiology SARS-CoV-2 Female Male Pandemics Adult Registries Cost of Illness Armed Conflicts COVID-19 epidemiology Refugees statistics & numerical data Communicable Diseases epidemiology
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article; Research Support, Non-U.S. Gov't Language: English [J Med Virol] 2024 May; Vol. 96 (5), pp. e29651. MeSH Terms: COVID-19* / epidemiology ; Refugees* / statistics & numerical data ; Communicable Diseases* / epidemiology ; Humans ; Ukraine / epidemiology ; Poland / epidemiology ; SARS-CoV-2 ; Female ; Male ; Pandemics ; Adult ; Registries ; Cost of Illness ; Armed Conflicts References: Betancourt JA, Rosenberg MA, Zevallos A, Brown JR, Mileski M. The impact of COVID‐19 on telemedicine utilization across multiple service lines in the United States. Healthcare. 2020;8(4):380. doi:10.3390/healthcare8040380. ; Ramakrishnan M, Poojari PG, Rashid M, Nair S, Pulikkel Chandran V, Thunga G. Impact of COVID‐19 pandemic on medicine supply chain for patients with chronic diseases: experiences of the community pharmacists. Clin Epidemiol Global Health. 2023;20(101243):101243. ; Ismail H, Marshall VD, Patel M, Tariq M, Mohammad RA. The impact of the COVID‐19 pandemic on medical conditions and medication adherence in people with chronic diseases. J Am Pharm Assoc. 2022;62(3):834‐839. ; Bazan D, Nowicki M, Rzymski P. Medical students as the volunteer workforce during the COVID‐19 pandemic: polish experience. Int J Disaster Risk Reduct. 2021;55(102109):102109. ; Peros G, Gronki F, Molitor N, et al. Organizing a COVID‐19 triage unit: a Swiss perspective. Emerg Microbes Infect. 2020;9(1):1506‐1513. ; Ahadian S, Pishvaee MS, Jahani H. Reorganization of a medical service network to manage pandemic waves: a real case study. Oper Res Health Care. 2023;39(100410):100410. ; De Filippis G, Cavazzana L, Gimigliano A, Piacenza M, Vimercati S. Covid‐19 pandemic: a frontline hospital reorganization to cope with therapeutic and diagnostic emergency. Pharmacol Res. 2020;161(105160):105160. ; Rzymski P, Falfushynska H, Fal A. Vaccination of Ukrainian refugees: need for urgent action. Clin Infect Dis. 2022;75(6):1103‐1108. doi:10.1093/cid/ciac276. ; Marchese V, Formenti B, Cocco N, et al. Examining the pre‐war health burden of Ukraine for prioritisation by European countries receiving Ukrainian refugees. Lancet Region Health. 2022;15(100369):100369. ; Venkatesan P. COVID‐19 diagnostics—not at the expense of other diseases. Lancet Microbe. 2020;1(2):e64. ; Onyeaka H, Anumudu CK, Al‐Sharify ZT, Egele‐Godswill E, Mbaegbu P. COVID‐19 pandemic: a review of the global lockdown and its far‐reaching effects. Sci Prog. 2021;104(2):003685042110198. ; Li H, Yuan K, Sun YK, et al. Efficacy and practice of facemask use in general population: a systematic review and meta‐analysis. Transl Psychiatry. 2022;12(1):49. ; Voidarou C, Rozos G, Stavropoulou E, et al. COVID‐19 on the spectrum: a scoping review of hygienic standards. Front Public Health. 2023;11:1202216. doi:10.3389/fpubh.2023.1202216. ; Li L, Taeihagh A, Tan SY. A scoping review of the impacts of COVID‐19 physical distancing measures on vulnerable population groups. Nat Commun. 2023;14(1):599. ; Li H, Ling F, Zhang S, et al. Comparison of 19 major infectious diseases during COVID‐19 epidemic and previous years in Zhejiang, implications for prevention measures. BMC Infect Dis. 2022;22(1):296. doi:10.1186/s12879-022-07301-w. ; Pan J, Zhan C, Yuan T, Sun Y, Wang W, Chen L. Impact of the COVID‐19 pandemic on infectious disease hospitalizations of neonates at a tertiary academic hospital: a cross‐sectional study. BMC Infect Dis. 2022;22(1):206. doi:10.1186/s12879-022-07211-x. ; Hirae K, Hoshina T, Koga H. Impact of the COVID‐19 pandemic on the epidemiology of other communicable diseases in Japan. Int J Infect Dis. 2023;128:265‐271. ; Levy C, Cohen R. Infectious diseases in the COVID‐19 era: gaps between countries. Lancet Infect Dis. 2023;23(9):987‐988. ; Tang HJ, Lai CC, Chao CM. The collateral effect of COVID‐19 on the epidemiology of airborne/droplet‐transmitted notifiable infectious diseases in Taiwan. Antibiotics. 2022;11(4):478. ; Yang MC, Su YT, Chen PH, Tsai CC, Lin TI, Wu JR. Changing patterns of infectious diseases in children during the COVID‐19 pandemic. Front Cell Infect Microbiol. 2023;13:1200617. doi:10.3389/fcimb.2023.1200617. ; van de Berg S, Charles T, Dörre A, Katz K, Böhm S. Epidemiology of common infectious diseases before and during the COVID‐19 pandemic in Bavaria, Germany, 2016 to 2021: an analysis of routine surveillance data. Euro Surveill. 2023;28(41):2300030. doi:10.2807/1560-7917.es.2023.28.41.2300030. ; Walport MJ, Professor Sir Mark Walport on behalf of the Expert Working Group for the Royal Society's programme on non‐pharmaceutical i. Executive summary to the royal society report “COVID‐19: examining the effectiveness of non‐pharmaceutical interventions. Philos Transact A Math Phys Eng Sci. 2023;381(2257):20230211. doi:10.1098/rsta.2023.0211. ; Shevlin M, Nolan E, Owczarek M, et al. COVID‐19‐related anxiety predicts somatic symptoms in the UK population. Br J Health Psychol. 2020;25(4):875‐882. ; Koçak O, Koçak ÖE, Younis MZ. The psychological consequences of COVID‐19 fear and the moderator effects of individuals' underlying illness and witnessing infected friends and family. Int J Environ Res Public Health. 2021;18(4):1836. ; Şimşir Z, Koç H, Seki T, Griffiths MD. The relationship between fear of COVID‐19 and mental health problems: a meta‐analysis. Death Stud. 2022;46(3):515‐523. ; Rzymski P, Pokorska‐Śpiewak M, Jackowska T, et al. Key considerations during the transition from the acute phase of the COVID‐19 pandemic: a narrative review. Vaccines. 2023;11(9):1502. ; National Institute of Public Health–National Research Institute. Reports on Infectious Diseases, Infections and Poisonings in Poland for the years 2016‐2023. Accessed February 4, 2024. https://wwwold.pzh.gov.pl/oldpage/epimeld/index_p.html. ; Temporary limitations ‐ Coronavirus: information and recommendations ‐ Gov.pl website. Coronavirus: information and recommendations. Accessed February 5, 2024. https://www.gov.pl/web/coronavirus/temporary-limitations. ; Про удосконалення проведення профілактичних щеплень в Україні. Офіційний вебпортал парламенту України. Accessed February 21, 2024. https://zakon.rada.gov.ua/laws/show/z1237-14. ; Orsini D, Martini M. Measles: a new danger for Ukraine's children! The need for an effective and timely vaccination prevention campaign. J Prev Med Hyg. 2023;64(2):E204. ; Tilles D Refusals of compulsory vaccines for children double in Poland over last five years. Notes From Poland. Accessed July 31, 2023. https://notesfrompoland.com/2023/04/26/refusals-of-compulsory-vaccines-for-children-double-in-poland-over-last-five-years/. ; GUS. Vaccinations of children and youth. stat.gov.pl. Accessed February 11, 2024. https://stat.gov.pl/en/topics/health/health/vaccinations-of-children-and-youth,5,4.html. ; Wong C. Measles outbreaks cause alarm: what the data say. Nature. 2024. doi:10.1038/d41586-024-00265-8. ; Malchrzak W, Babicki M, Mastalerz‐Migas A. Vaccination against streptococcus pneumoniae in children born between 2015 and 2018 in Poland—how has the introduction of free compulsory pneumococcal vaccination affected its uptake? Vaccines. 2023;11(11):1654. ; Wróbel‐Pawelczyk I, Ronkiewicz P, Wanke‐Rytt M, et al. Pneumococcal carriage in unvaccinated children at the time of vaccine implementation into The National Immunization Program in Poland. Sci Rep. 2022;12(1):5858. ; Jain H, Sulaiman SA, Pokhrel P, Khan NU, Verma A. Unveiling the recent outbreak of legionella in Poland: approaches and obstacles – an editorial. Ann Med Surg. 2023;85(12):5855‐5858. ; Szymanski M, Śmietana JH, Jaworski WR, Skiba MM, Piasecka M, Olender A. A case of legionnaires' disease in a patient during the legionella epidemic in south‐eastern Poland in August 2023. Pol Arch Med Wewn. 2023;133(10):16584. doi:10.20452/pamw.16584. ; Sidor A, Rzymski P. Dietary choices and habits during COVID‐19 lockdown: experience from Poland. Nutrients. 2020;12(6):1657. ; Fu Y, Luo Y, Grinspan AM. Epidemiology of community‐acquired and recurrent Clostridioides difficile infection. Therap Adv Gastroenterol. 2021;14:175628482110162. ; Ochoa‐Hein E, Rajme‐López S, Rodríguez‐Aldama JC, et al. Substantial reduction of healthcare facility‐onset clostridioides difficile infection (HO‐CDI) rates after conversion of a hospital for exclusive treatment of COVID‐19 patients. Am J Infect Control. 2021;49(7):966‐968. ; Bentivegna E, Alessio G, Spuntarelli V, et al. Impact of COVID‐19 prevention measures on risk of health care‐associated clostridium difficile infection. Am J Infect Control. 2021;49(5):640‐642. ; Ponce‐Alonso M, Sáez de la Fuente J, Rincón‐Carlavilla A, et al. Impact of the coronavirus disease 2019 (COVID‐19) pandemic on nosocomial Clostridioides difficile infection. Infecti Control Hosp Epidemiol. 2021;42(4):406‐410. ; Choi KB, Du T, Silva A, et al. Trends in Clostridioides difficile infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID‐19) pandemic. Infect Control Hosp Epidemiol. 2023;44(7):1180‐1183. ; Garg SK. Antibiotic misuse during COVID‐19 pandemic: a recipe for disaster. Ind J Critic Care Med. 2021;25(6):617‐619. ; Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID‐19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022. EClinicalMedicine. 2023;57(101848):101848. ; Malik SS, Mundra S. Increasing consumption of antibiotics during the COVID‐19 pandemic: implications for patient health and emerging anti‐microbial resistance. Antibiotics. 2022;12(1):45. ; Bernatz JT, Safdar N, Hetzel S, Anderson PA. Antibiotic overuse is a major risk factor for Clostridium difficile infection in surgical patients. Infect Control Hosp Epidemiol. 2017;38(10):1254‐1257. ; Mullish BH, Williams HR. Clostridium difficile infection and antibiotic‐associated diarrhoea. Clin Med. 2018;18(3):237‐241. ; Dobrowolska K, Brzdęk M, Zarębska‐Michaluk D, et al. Differences between the course of SARS‐CoV‐2 infections in the periods of the delta and omicron variants dominance in Poland. Pol Arch Intern Med. 2023;133(5):16403. doi:10.20452/pamw.16403. ; Flisiak R, Rzymski P, Zarębska‐Michaluk D, et al. Variability in the clinical course of COVID‐19 in a retrospective analysis of a large real‐world database. Viruses. 2023;15(1):149. ; Cohen R, Martinón‐Torres F, Posiuniene I, Benninghoff B, Oh KB, Poelaert D. The value of rotavirus vaccination in Europe: a call for action. Infect Dis Ther. 2023;12(1):9‐29. ; Bernstein DI, Sander DS, Smith VE, Schiff GM, Ward RL. Protection from rotavirus reinfection: 2‐year prospective study. J Infect Dis. 1991;164(2):277‐283. ; Gladstone BP, Ramani S, Mukhopadhya I, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med. 2011;365(4):337‐346. ; Toczylowski K, Jackowska K, Lewandowski D, Kurylonek S, Waszkiewicz‐Stojda M, Sulik A. Rotavirus gastroenteritis in children hospitalized in northeastern Poland in 2006–2020: severity, seasonal trends, and impact of immunization. Int J Infect Dis. 2021;108:550‐556. ; Burnett E, Parashar UD, Tate JE. Global impact of rotavirus vaccination on diarrhea hospitalizations and deaths among children <5 years old: 2006‐2019. J Infect Dis. 2020;222(10):1731‐1739. ; Simmons K, Gambhir M, Leon J, Lopman B. Duration of immunity to norovirus gastroenteritis. Emerg Infect Dis. 2013;19(8):1260‐1267. ; Lopman BA, Steele D, Kirkwood CD, Parashar UD. The vast and varied global burden of norovirus: prospects for prevention and control. PLoS Med. 2016;13(4):e1001999. ; Inns T, Wilson D, Manley P, Harris JP, O'Brien SJ, Vivancos R. What proportion of care home outbreaks are caused by norovirus? An analysis of viral causes of gastroenteritis outbreaks in care homes, North East England, 2016–2018. BMC Infect Dis. 2020;20(1):2. doi:10.1186/s12879-019-4726-4. ; Nieradko‐Iwanicka B, Iwanicki J, Dyczewski B, Herbet M. The COVID‐19 – related problems encountered by nursing homes in Poland and the steps undertaken to prevent disease spread in the first phase of the epidemic. Curr Issues Pharm Med Sci. 2021;34(4):206‐211. ; Jacobsen S, Faber M, Altmann B, Mas Marques A, Bock CT, Niendorf S. Impact of the COVID‐19 pandemic on norovirus circulation in Germany. IJMM. 2024;314(151600):151600. ; Ganczak M, Michalska J, Pasek O, Sikora A. Wearing masks in public spaces in Poland during SARS‐Cov‐2 epidemic: an observational study. Eur J Pub Health. 2021;31(suppl ment_3):ckab165.061. ; Tabak YP, Srinivasan A, Yu KC, et al. Hospital‐level high‐risk antibiotic use in relation to hospital‐associated Clostridioides difficile infections: retrospective analysis of 2016–2017 data from US hospitals. Infect Control Hosp Epidemiol. 2019;40(11):1229‐1235. ; Burki T. Vaccine misinformation and social media. Lancet Digit Health. 2019;1(6):e258‐e259. ; Genowska A, Zarębska‐Michaluk D, Strukcinskiene B, et al. Changing epidemiological patterns of infection and mortality due to hepatitis C virus in Poland. J Clin Med. 2023;12(12):3922. ; Kondili LA, Buti M, Riveiro‐Barciela M, et al. Impact of the COVID‐19 pandemic on hepatitis B and C elimination: an EASL survey. JHEP Reports. 2022;4(9):100531. ; Rzymski P, Zarębska‐Michaluk D, Genowska A, Tyszko P, Strukcinskiene B, Flisiak R. Trends of hepatitis A virus infection in Poland: assessing the potential impact of the COVID‐19 pandemic and war in Ukraine. Viruses. 2024;16(3):469. ; Guidance for country validation of viral hepatitis elimination and path to elimination. Accessed February 11, 2024. https://www.who.int/publications/i/item/9789240078635. ; Tomasiewicz K, Flisiak R, Jaroszewicz J, et al. Recommendations of the polish group of experts for HCV for the treatment of hepatitis C in 2023. Clin Exp Hepatol. 2023;9(1):1‐8. ; Qaderi K, Yazdkhasti M, Zangeneh S, et al. Changes in sexual activities, function, and satisfaction during the COVID‐19 pandemic era: a systematic review and meta‐analysis. Sex Med. 2023;11(2):005. doi:10.1093/sexmed/qfad005. ; Starks TJ, Jones SS, Sauermilch D, et al. Evaluating the impact of COVID‐19: a cohort comparison study of drug use and risky sexual behavior among sexual minority men in the U.S.A. Drug Alcohol Depend. 2020;216(108260):108260. ; Wang S, Yang J, Niu D, et al. Change of sexual behavior among men who have sex with men before, during and after COVID‐19 pandemic in China: a cross‐sectional study. BMC Infect Dis. 2023;23(1):527. doi:10.1186/s12879-023-08488-2. ; Simões D, Stengaard AR, Combs L, Raben D. The EuroTEST COVID‐19 impact assessment consortium of partners. Impact of the COVID‐19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Euro Surveill. 2020;25(47):2001943. doi:10.2807/1560-7917.es.2020.25.47.2001943. ; European Centre for Disease Prevention and Control, WHO Regional Office for Europe. HIV/AIDS Surveillance in Europe 2021: 2020 Data.; 2021. ; Rick F, Odoke W, van den Hombergh J, Benzaken AS, Avelino‐Silva VI. Impact of coronavirus disease (COVID‐19) on HIV testing and care provision across four continents. HIV Med. 2022;23(2):169‐177. ; Mann LM, Sanchez T, Stephenson R, Sullivan PS, Jenness SM. The impact of the COVID‐19 pandemic on sexual behavior and HIV prevention and treatment services among U.S. men who have sex with men in the post‐lockdown era. American Journal of Men's Health. 2023;17(2):155798832311686. ; Yang J, Yi M, Qian HZ, Chen Y, Zhou Q, Li X. Post‐lockdown rebounding high‐risk behaviors and HIV testing among MSM in China in the era of the COVID‐19 pandemic. Curr HIV Res. 2022;20(4):287‐295. ; Vasylyev M, Skrzat‐Klapaczyńska A, Bernardino JI, et al. Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war‐struck Ukraine. The Lancet HIV. 2022;9(6):e438‐e448. ; Ukrainian citizens in Poland – current migration data. Office for Foreigners. Published 2023. Accessed October 4, 2023. https://www.gov.pl/web/udsc/obywatele-ukrainy-w-polsce--aktualne-dane-migracyjne. ; Kosendiak AA, Wysocki M, Krysiński P, Kuźnik Z, Adamczak B. Impact of the COVID‐19 pandemic on physical activity, smoking, alcohol use, and mental well‐being—a longitudinal study of nursing students at Wroclaw Medical University in Poland. Front Public Health. 2023;11:1249509. doi:10.3389/fpubh.2023.1249509. ; Noszczyk T, Gorzelany J, Kukulska‐Kozieł A, Hernik J. The impact of the COVID‐19 pandemic on the importance of urban Green spaces to the public. Land use policy. 2022;113(105925):105925. ; Moniuszko‐Malinowska A, Pancewicz S, Czupryna P. Has COVID‐19 influenced on tick‐borne epidemiology? Przegl Epidemiol. 2020;74(4):740‐741. ; McCormick DW, Kugeler KJ, Marx GE, et al. Effects of COVID‐19 pandemic on reported lyme disease, United States, 2020. Emerg Infect Dis. 2021;27(10):2715‐2717. ; Nuttall PA. Climate change impacts on ticks and tick‐borne infections. Biologia. 2022;77(6):1503‐1512. ; Guérin M, Shawky M, Zedan A, et al. Lyme borreliosis diagnosis: state of the art of improvements and innovations. BMC Microbiol. 2023;23(1):204. doi:10.1186/s12866-023-02935-5. ; Michael Y, Shaukat NM. Erysipelas. StatPearls Publishing; 2023. ; Becq‐Giraudon B. Primary and secondary prevention for erysipelas. Ann Dermatol Venereol. 2001;128(3 Pt 2):368‐375. ; Białynicki‐Birula R, Siemasz I, Otlewska A, Matusiak Ł, Szepietowski JC. Influence of COVID ‐19 pandemic on hospitalizations at the tertiary dermatology department in south‐west Poland. Dermatol Ther. 2020;33(4):e13738. doi:10.1111/dth.13738. ; Litchman GH, Rigel DS. The immediate impact of COVID‐19 on US dermatology practices. J Am Acad Dermatol. 2020;83(2):685‐686. ; Bhargava S, Negbenebor N, Sadoughifar R, Ahmad S, Kroumpouzos G. Global impact on dermatology practice due to the COVID‐19 pandemic. Clin Dermatol. 2021;39(3):479‐487. ; Ministry of Health in Poland. Zarządzenie Ministra Zdrowia z dnia 11 stycznia 2024 r. w sprawie powołania Zespołu do spraw monitorowania i oceny sytuacji dotyczącej zagrożeń związanych z chorobami zakaźnymi. Published 2024. Accessed March 28, 2024. https://dziennikmz.mz.gov.pl/DUM_MZ/2024/2/akt.pdf. Contributed Indexing: Keywords: SARS‐CoV‐2; airborne diseases; epidemiology; fecal‐oral route; foodborne diseases; sexually‐transmitted diseases; tick‐borne diseases; viral hepatitis Entry Date(s): Date Created: 20240507 Date Completed: 20240507 Latest Revision: 20240507 Update Code: 20240507

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration.